Dapagliflozin in HFrEF Patients Treated With Mineralocorticoid Receptor Antagonists
Li Shen, Søren Lund Kristensen, Olof Bengtsson, Michael Böhm, Rudolf A. de Boer, Kieran F. Docherty, Silvio E. Inzucchi, Tzvetana Katova, Lars Køber, Mikhail Kosiborod, Anna Maria Langkilde, Daniel Lindholm, M. Felipe A. Martinez, Eileen O’Meara, José Carlos Nicolau, Mark C. Petrie, Piotr Ponikowski, Marc S. Sabatine, Morten Schou, Mikaela Sjöstrand, Scott D. Solomon, Pardeep S. Jhund, John J.V. McMurray
Topics & Concepts
MedicineDapagliflozinMineralocorticoid receptorInternal medicineMineralocorticoidHeart failureAldosteroneEndocrinologyPharmacologyCardiologyDiabetes mellitusType 2 diabetesDiabetes Treatment and ManagementHormonal Regulation and HypertensionCardiovascular Function and Risk Factors